201. TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation
- Author
-
Tak W. Mak, Arnold J. Levine, Gerry Melino, Satoshi Inoue, Richard A. Knight, Ivano Amelio, and E K Markert
- Subjects
Vascular Endothelial Growth Factor A ,Lung Neoplasms ,Angiogenesis ,P53 family ,Inbred C57BL ,Mice ,Neoplasms ,Tumor Protein p73 ,P73 ,Tumor progression ,Tumor vascularization ,VEGF ,Adenocarcinoma ,Animals ,Cell Line, Tumor ,DNA-Binding Proteins ,Disease Progression ,Gene Deletion ,Humans ,Hypoxia-Inducible Factor 1, alpha Subunit ,In Vitro Techniques ,Mice, Inbred C57BL ,Neovascularization, Pathologic ,Nuclear Proteins ,Proteasome Endopeptidase Complex ,Protein Binding ,Proto-Oncogene Proteins c-mdm2 ,Signal Transduction ,Survival Analysis ,Tumor Suppressor Proteins ,Ubiquitin ,Ubiquitination ,Xenograft Model Antitumor Assays ,Proteolysis ,Multidisciplinary ,Tumor ,Biological Sciences ,Hypoxia-inducible factors ,Hypoxia-Inducible Factor 1 ,Adenocarcinoma of Lung ,Biology ,alpha Subunit ,Cell Line ,ddc:570 ,medicine ,Settore BIO/10 ,Transcription factor ,Neovascularization ,Pathologic ,Tumor hypoxia ,Cancer ,medicine.disease ,Molecular biology ,HIF1A ,Cancer research - Abstract
Tumor hypoxia and hypoxia-inducible factor 1 (HIF-1) activation are associated with cancer progression. Here, we demonstrate that the transcription factor TAp73 opposes HIF-1 activity through a nontranscriptional mechanism, thus affecting tumor angiogenesis. TAp73-deficient mice have an increased incidence of spontaneous and chemically induced tumors that also display enhanced vascularization. Mechanistically, TAp73 interacts with the regulatory subunit (α) of HIF-1 and recruits mouse double minute 2 homolog into the protein complex, thus promoting HIF-1α polyubiquitination and consequent proteasomal degradation in an oxygen-independent manner. In human lung cancer datasets, TAp73 strongly predicts good patient prognosis, and its expression is associated with low HIF-1 activation and angiogenesis. Our findings, supported by in vivo and clinical evidence, demonstrate a mechanism for oxygen-independent HIF-1 regulation, which has important implications for individualizing therapies in patients with cancer. published
- Published
- 2014